Question to the Department for Science, Innovation & Technology:

To ask the Secretary of State for Science, Innovation and Technology, if she will publish a breakdown of the investments allocated to each of the four recipient companies of the Government’s Life Sciences Innovation Manufacturing Fund grants by proportion of public and private sector for each investment.

The first four grant recipients of the Life Sciences Innovative Manufacturing Fund were announced on 28th March 2023, which saw £277 million in joint government and industry backing to help Life Sciences companies grow and innovate.

Government grants have been supported by private investment from the successful companies. The proportion of the funding for each of the investments is as follows:

• Ipsen: 4% public, 96% private;
• Pharmaron Biologics UK: 7% public, 93% private;
• Randox Laboratories Ltd: 4% public, 96% private;
• Touchlight Genetics Ltd: 18% public, 82% private.